State LA
Clinical Trials in Louisiana
Recruiting clinical trials with at least one study location in Louisiana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Louisiana
Peripheral Artery Disease (3)Chronic Lymphocytic Leukemia (3)Asthma (2)Hypertension (2)Small Lymphocytic Lymphoma (2)Endometrial Cancer (2)Anatomic Stage II Breast Cancer AJCC v8 (2)RISS Stage I Plasma Cell Myeloma (2)RISS Stage II Plasma Cell Myeloma (2)Idiopathic Short Stature (2)Acute Myeloid Leukemia (2)Obesity (2)
Frequently Asked Questions — Clinical Trials in Louisiana
How many clinical trials are currently recruiting in Louisiana?
ClinicalMetric currently tracks 125 actively recruiting clinical trials with at least one location in Louisiana. The total number of registered studies—including active but not currently enrolling trials—is 125. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Louisiana?
Louisiana hosts clinical trials across a broad range of medical conditions, including Peripheral Artery Disease, Chronic Lymphocytic Leukemia, Asthma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Louisiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Louisiana?
To join a clinical trial in Louisiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Louisiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Louisiana
NCT06016842 Phase 3
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Chol...
Condition
Primary Biliary Cholangitis (PBC)
Enrollment
276 pts
Location
United States, Argentina, Australia
Sponsor
Ipsen
NCT06472245 Phase 3
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung...
Condition
Patients With Non-Small Cell Lung Cancer
Enrollment
363 pts
Location
United States, Belgium, Canada
Sponsor
OSE Immunotherapeutics
NCT04433572 Phase 3
Recruiting
Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Reva...
Condition
Peripheral Artery Disease
Enrollment
250 pts
Location
United States
Sponsor
Mercator MedSystems, Inc.
NCT04661358 Phase 3
Recruiting
Fenofibrate for Prevention of DR Worsening
Condition
Diabetic Retinopathy
Enrollment
560 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
NCT06249555 N/A
Recruiting
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With C...
Condition
Crohn's Disease
Enrollment
300 pts
Location
United States, Canada
Sponsor
Alimentiv Inc.
NCT06712940 N/A
Recruiting
Supportive Hospital-Based Intervention for Firearm Trauma
Condition
Gun Violence Prevention
Enrollment
350 pts
Location
United States
Sponsor
Tulane University
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT05219617 Phase 3
Recruiting
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizu...
Condition
Seizures
Enrollment
252 pts
Location
United States, Argentina, Australia
Sponsor
SK Life Science, Inc.
NCT06832306 N/A
Recruiting
STimulation to Activate RespIration
Condition
ARDS (Moderate or Severe)
Enrollment
30 pts
Location
United States, Canada
Sponsor
Lungpacer Medical Inc.
NCT07220460 Phase 2
Recruiting
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With D...
Condition
Bipolar I or II Disorder
Enrollment
200 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
NCT05828069 Phase 2
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapse...
Condition
Recurrent Langerhans Cell Histiocytosis
Enrollment
48 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06967805 Phase 2
Recruiting
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis...
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
164 pts
Location
United States, Argentina, Australia
Sponsor
Mediar Therapeutics
NCT05692180 Phase 3
Recruiting
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Tim...
Condition
Asthma
Enrollment
200 pts
Location
United States, Argentina, Canada
Sponsor
AstraZeneca
NCT04678154 Phase 3
Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fr...
Condition
Post Operative Surgical Site Infection
Enrollment
1,200 pts
Location
United States
Sponsor
Major Extremity Trauma Researc
NCT06963827 Phase 3
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Condition
Kidney Disease
Enrollment
347 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
NCT05611242 Phase 3
Recruiting
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlu...
Condition
Acute Ischemic Stroke
Enrollment
404 pts
Location
United States
Sponsor
Mercy Health Ohio
NCT06133322 N/A
Recruiting
Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSE...
Condition
Hypertension
Enrollment
1,176 pts
Location
United States
Sponsor
Tulane University
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
510 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
NCT04239573 N/A
Recruiting
Comparing Two Methods to Follow Patients With Pancreatic Cysts
Condition
Pancreatic Carcinoma
Enrollment
4,606 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT06993610 Phase 2
Recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Condition
Hidradenitis Suppurativa (HS)
Enrollment
225 pts
Location
United States, Canada, Germany
Sponsor
Zura Bio Inc
NCT06926868 Phase 2, Phase 3
Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Prev...
Condition
Breast Neoplasms
Enrollment
500 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT07061613 N/A
Recruiting
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for ...
Condition
Venous Leg Ulcer
Enrollment
10 pts
Location
United States
Sponsor
NuScience Medical Biologics, L
NCT02843945 Phase 1, Phase 2
Recruiting
Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With ...
Condition
Pancreatic Cancer
Enrollment
80 pts
Location
United States
Sponsor
CivaTech Oncology
NCT07288138 Phase 2
Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicar...
Condition
Metabolic Dysfunction-associated Steatohepatitis
Enrollment
160 pts
Location
United States
Sponsor
Eccogene
Page 1 of 5 — 125 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology